Subclinical central nervous system involvement and thrombophilic status in young thalassemia intermedia patients of Greek origin

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 3, 2012, Pages 195-202

  Teli, Aikaterini ^a   Economou, Marina ^a   Rudolf, Jobst ^b   Tzovaras, Filimon ^a   Gourtsa, Vaia ^a   Kondou, Antonia ^a   Kontopoulos, Eleftherios ^a   Gombakis, Nikolaos ^a   Athanassiou Metaxa, Miranda ^a   Zafeiriou, Dimitrios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

Author keywords

adolescents; central nervous system; children; thalassemia intermedia; thrombophilic status

Indexed keywords

CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S;

ADOLESCENT; ADULT; ANTERIOR CEREBRAL ARTERY; ARTICLE; BASILAR ARTERY; BETA THALASSEMIA; CENTRAL NERVOUS SYSTEM; CHILD; CROSS-SECTIONAL STUDY; DOPPLER ECHOGRAPHY; ELECTROENCEPHALOGRAM; EVOKED AUDITORY RESPONSE; EVOKED BRAIN STEM AUDITORY RESPONSE; EVOKED SOMATOSENSORY RESPONSE; EVOKED VISUAL RESPONSE; GREECE; HEMATOCRIT; HETEROZYGOSITY; HUMAN; INTELLIGENCE QUOTIENT; INTERNAL CAROTID ARTERY; MIDDLE CEREBRAL ARTERY; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL THROMBOPLASTIN TIME; POSTERIOR CEREBRAL ARTERY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTHROMBIN TIME; SCHOOL CHILD; THROMBOPHILIA;

ADOLESCENT; ANTITHROMBIN III; BETA-THALASSEMIA; BLOOD COAGULATION; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ELECTROENCEPHALOGRAPHY; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; GREECE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; NEUROPSYCHOLOGICAL TESTS; PEPTIDE HYDROLASES; PLATELET COUNT; PROTEIN C; PROTEIN S; YOUNG ADULT;

EID: 84859435182     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32834f0ac0     Document Type: Article

References (42)

1. Borgna Pignatti C, Marsella M, Zanforlin N. The natural history of thalassemia intermedia. Ann N Y Acad Sci 2010; 1202:214-220.
2. Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood 2010; 115:1886-1892.
3. Logothetis J, Constantoulakis M, Economidou J, Stefanis C, Hakas P, Augoustaki O, et al. Thalassemia major (homozygous beta-thalassemia). A survey of 138 cases with emphasis on neurologic and muscular aspects. Neurology 1972; 22:294-304.
4. Mutalimova AB. Features of cerebrovascular disorders in children with beta thalassemia major. Zh Nevropath Psikhiatr Im S S Korsakova 1975; 75:1484-1489.
5. Karimi M, Khanlari M, Rachmilewitz EA. Cerebrovascular accident in b-thalassemia major and thalassemia intermedia. Am J Hematol 2008; 82:77-79.
6. Leroy I, Liesner R, Saint-Martin C, et al. Central venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain 2005; 128:477-489. (Pubitemid 40380184)
7. Manfre L, Giarratano E, Maggio A, Banco A, Vaccaro G, Lagalla R. MR imaging of the brain: findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease. AJR 1999; 173:1477-1480.
8. Karimi M, Bagheri H, Rastgu F, Rachmilewitz EA. Magnetic resonance imaging to determine the incidence of brain ischaemia in patients with betathalassaemia intermedia. Thromb Haemost 2010; 103:989-993.
9. Taher AT, Musallam KM, Nasreddine W, Hourani R, Inati A, Beydoun A. Asymptomatic brain resonance imaging abnormalities in splenectomized adults with thalassemia intermedia. J Thromb Haemost 2010; 8:54-59.
10. Miller ST, Macklin EA, Pegelow CH, Kinney TR, Sleeper LA, Bello J, et al. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr 2001; 139:385-390. (Pubitemid 32889515)
11. Armstrong FD, Thompson RJ Jr, Wang W, Zimmerman R, Pegelow GH, Miller S, et al. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics 1996; 97:864-870. (Pubitemid 26170948)
12. Bernaudin F, Verlhac S, Fréard F, Roudot-Thoraval F, Benkerrou M, Thuret I, et al. Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation. J Child Neurol 2000; 15: 333-343. (Pubitemid 30341365)
13. Brown RT, Davis PC, Lambert R, Hsu L, Hopkins K, Eckman J, et al. Neurocognitive functioning and magnetic resonance imaging in children with sickle cell disease. J Pediatr Psychol 2000; 25:503-513.
14. Panigrahi I, Agatwal S. Thromboembolic complications in b-thalassemia: beyond the horizon. Thromb Res 2007; 120:783-789. (Pubitemid 47422335)
15. Moratelli S, De Sanktis V, Gemmati D, Serino ML, Mari R, Gamberini MR, et al. Thrombotic risk in thalassemic patients. J Pediatr Endocrinol Metab 1998; 11:915-921.
16. Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci AP. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassemia intermedia. Br J Haematol 2000; 111:467-473. (Pubitemid 32009338)
17. Eldor A, Durst R, Hy-Am E, Goldfarb A, Gillis S, Rachmilewitz EA, et al. A chronic hypercoagulable state in patients with beta-thalassemia major is already present in childhood. Br J Haematol 1999; 107:739-746. (Pubitemid 30020144)
18. Rahimi Z, Ghaderi M, Nagel RL, Muniz A. Prevalence of thrombotic risk factors among beta thalassemia patients from Western Iran. J Thromb Thrombolysis 2008; 26:229-233.
19. Eldor A, Rachmilewitz AE. The hypercoagulable state in thalassemia. Blood 2002; 99:36-43.
20. Taher A, Otrock ZK, Uthman I, Cappellini MD. Thalassemia and hypercoagulability. Blood Rev 2008; 22:283-292.
21. Cappellini MD, Motta I, Musallam KM, Taher A. Redefining thalassemia as a hypercoagulable state. Ann N Y Acad Sci 2010; 1202:231-236.
22. Taher A, Musallam MK, Inati A. The hypercoagulable state in thalassemia intermedia. Hemoglobin 2009; 33:160-169.
23. Verlhac S. Transcranial Doppler in children. Pediatr Radiol 2011; 41: 153-165.
24. Bode H, Wais U. Age dependence of flow velocities in basal arteries. Arch Dis Child 1988; 63:601-611.
25. Borna Pignatti C, Carnelli V, Caruso V, Dore F, De Mattia D, Di Palma A, et al. Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol 1998; 99:76-79. (Pubitemid 28119099)
26. Michaeli J, Mittelman M, Grisaru D, Rachmilewitz EA. Thromboembolic complications in beta thalassemia major. Acta Haematol 1992; 87:71-74.
27. Taher A, Ismaeel H, Melio G, Bignamini D, Kattamis A, Rachmilewitz EZ, et al. Prevalence of thromboembolic events among 8860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Tromb Haemost 2006; 96:488-491. (Pubitemid 44560684)
28. Metarugcheep P, Chanyawattiwongs S, Srisubat K, Pootrakul P. Clinical silent cerebral infarct (SCI) in patients with thalassemia diseases assessed by magnetic resonance imaging (MRI). J Med Assoc Thai 2008; 91: 889-894. (Pubitemid 351977870)
29. Amabile G, Stefano E, Bianco I, Aliquo MC, Giunti P, Pierelli F, et al. Electrophysiological (EGG, BAEP, VEP) study in patients with betathalassemia major. Acta Neurol Belg 1987; 87:181-190.
30. Economou M, Zafeiriou DI, Kontopoulos E, Gompakis N, Koussi A, Perifanis V, et al. Neurophysiologic and intellectual evaluation of beta-thalassemia patients. Brain Dev 2006; 28:14-18. (Pubitemid 43042432)
31. Zafeiriou DI, Kousi AA, Tsantali CT, Kontopoulos EE, Augoustidou- Savvopoulou PA, Athanasiou MA. Neurophysiologic evaluation of long-term desferrioxamine therapy in beta-thalassemia patients. Pediatr Neurol 1998; 18:420-424. (Pubitemid 28308710)
32. Marciani MG, Cianciulli P, Stefani N, Stefanini F, Peroni L, Sabbadini M, et al. Toxic effects of high-dose deferoxamine treatment in patients with iron overload: an electrophysiological study of cerebral and visual function. Haematologica 1991; 76:131-134.
33. Wong V, Li A, Lee AC. Neurophysiologic study of beta-thalassemia patients. J Child Neurol 1993; 8:330-335.
34. Triantafyllou N, Fisfis M, Sideris G, Triantafyllou D, Rombos A, Vrettou H, et al. Neurophysiological and neuro-otological study of homozygous betathalassemia under long-term desferrioxamine (DFO) treatment. Acta Neurol Scand 1991; 83:306-308.
35. McKie V, Nichols F, Carl E, Zhang DL, McKie K, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992; 326:605-610.
36. Adams R, McKie V, Carl E, Nichols FT, Perry R, Brock K, et al. Long term stroke risk in children with sickle cell disease screened with transranial Doppler. Ann Neurol 1997; 42:699-704. (Pubitemid 27481541)
37. Abboud M, Cure J, Granger S, Gallagher D, Hsu L, Wang W, et al. Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood 2004; 103:3689-3694.
38. Bernaudin F, Verlach S, Arnaud C, Kamderm A, Chernet S, Hau I, et al. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell cohort. Blood 2010; 117:1130-1140.
39. Shirahata A, Funahara Y, Opartkiattikul N, Fucharoen S, Laosombat V, Yamada K. Protein C and protein S deficiency in thalassemic patients. Southeast Asian J Trop Med Public Health 1992; 23:65-73.
40. Musumeci S, Leonardi S, Di Dio R, Fischer A, Di Costa G. Protein C and antithrombin III in polytransfused thalassemic patients. Acta Haematol 1987; 77:30-33. (Pubitemid 17071855)
41. Zalloua PA, Shbaklo H, Mourad YA, Koussa S, Taher A. Incidence of thromboembolic events in Lebanese thalassemia intermedia patients. Thromb Haemost 2003; 89:767-768. (Pubitemid 36456977)
42. Antoniadi T, Hatzis T, Kroupis C, Economou-Petersen E, Petersen MB. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors. Am J Hematol 1999; 61:265-267. (Pubitemid 29355025)